G. Idéo

5.7k total citations · 1 hit paper
99 papers, 4.4k citations indexed

About

G. Idéo is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, G. Idéo has authored 99 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Hepatology, 61 papers in Epidemiology and 16 papers in Surgery. Recurrent topics in G. Idéo's work include Liver Disease Diagnosis and Treatment (54 papers), Hepatitis C virus research (42 papers) and Liver Disease and Transplantation (23 papers). G. Idéo is often cited by papers focused on Liver Disease Diagnosis and Treatment (54 papers), Hepatitis C virus research (42 papers) and Liver Disease and Transplantation (23 papers). G. Idéo collaborates with scholars based in Italy, France and United States. G. Idéo's co-authors include Jenny Heathcote, C. Trépo, Samuel S. Lee, Christian Niederau, Patrick Marcellin, Gerald Minuk, Vincent G. Bain, Stefan Zeuzem, Thierry Poynard and Janice K. Albrecht and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Gastroenterology.

In The Last Decade

G. Idéo

99 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

1998 1.9k citations G. Idéo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Idéo Italy	29	3.6k	3.3k	531	389	270	99	4.4k
John C. Hoefs United States	30	3.8k 1.1×	3.5k 1.0×	848 1.6×	340 0.9×	381 1.4×	73	5.2k
Harald Hofer Austria	32	3.0k 0.8×	2.7k 0.8×	537 1.0×	463 1.2×	247 0.9×	73	4.0k
Donald M. Jensen United States	36	3.7k 1.0×	3.7k 1.1×	317 0.6×	386 1.0×	594 2.2×	114	4.8k
Thomas Kiernan United States	11	3.0k 0.8×	3.1k 0.9×	289 0.5×	336 0.9×	135 0.5×	21	4.0k
Luis A. Balart United States	23	2.9k 0.8×	2.7k 0.8×	448 0.8×	489 1.3×	173 0.6×	64	4.0k
Piero Luigi Almasio Italy	32	2.1k 0.6×	2.2k 0.7×	535 1.0×	265 0.7×	142 0.5×	111	3.1k
Akihiro Matsumoto Japan	37	3.1k 0.9×	3.3k 1.0×	576 1.1×	424 1.1×	353 1.3×	132	4.4k
Robert L. Carithers United States	33	3.2k 0.9×	2.7k 0.8×	1.0k 1.9×	279 0.7×	187 0.7×	70	4.2k
Jeanne G. Waggoner United States	33	3.9k 1.1×	3.6k 1.1×	211 0.4×	499 1.3×	335 1.2×	58	5.2k
Jee‐Fu Huang Taiwan	38	3.9k 1.1×	4.0k 1.2×	432 0.8×	368 0.9×	279 1.0×	290	5.4k

Countries citing papers authored by G. Idéo

Since Specialization

Citations

This map shows the geographic impact of G. Idéo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Idéo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Idéo more than expected).

Fields of papers citing papers by G. Idéo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Idéo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Idéo. The network helps show where G. Idéo may publish in the future.

Co-authorship network of co-authors of G. Idéo

This figure shows the co-authorship network connecting the top 25 collaborators of G. Idéo. A scholar is included among the top collaborators of G. Idéo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Idéo. G. Idéo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carbone, Marco, Laura Cristoferi, Paolo Angelo Cortesi, et al.. (2017). Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(4). 1415–1422. 3 indexed citations

Scalone, L, Paolo Angelo Cortesi, Roberta Ciampichini, et al.. (2012). PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases. Value in Health. 15(7). A332–A332. 1 indexed citations

Bruno, Savino, Pier Maria Battezzati, G. Bellati, et al.. (2001). Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C. Journal of Hepatology. 34(5). 748–755. 66 indexed citations

Bellobuono, A., et al.. (2000). Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy. Journal of Hepatology. 33(3). 463–468. 14 indexed citations

Mondazzi, L., et al.. (1999). Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?. Journal of Hepatology. 30(1). 8–13. 12 indexed citations

Belli, L, Claudio Zavaglia, A. Albertí, et al.. (1999). Immunogenetic factors, HCV genotypes, and HCV recurrence after liver transplantation. Transplantation Proceedings. 31(1-2). 483–484. 2 indexed citations

Colloredo, Guido, G. Bellati, Aurelio Sonzogni, et al.. (1999). Semiquantitative assessment of IgM antibody to hepatitis B core antigen and prediction of the severity of chronic hepatitis B. Journal of Viral Hepatitis. 6(6). 429–434. 11 indexed citations

Albertí, A., P.L. Almasio, Antonio Ascione, et al.. (1997). Guidelines for the treatment of chronic viral hepatitis. 29(6). 597–600. 4 indexed citations

Zavaglia, Claudio, L. Mondazzi, Giovanni Maggi, et al.. (1997). Are alanine aminotransferase, hepatitis B virus DNA or IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronic hepatitis B?. Liver International. 17(2). 83–87. 24 indexed citations

10.

Albertí, A., L Belli, Enrico Maria Silini, et al.. (1997). Hepatitis C virus genotypes and severe hepatitis C virus recurrence after liver transplantation. Transplantation Proceedings. 29(1-2). 522–523. 2 indexed citations

11.

Andreoné, Pietro, Carmela Cursaro, Annagiulia Gramenzi, et al.. (1996). A Randomized Controlled Trial of Thymosin–α1 Versus Interferon Alfa Treatment in Patients With Hepatitis B E Antigen Antibody—And Hepatitis B Virus Dna—Positive Chronic Hepatitis B. Hepatology. 24(4). 774–777. 60 indexed citations

12.

Zavaglia, Claudio, R. Bottelli, Antonina Smedile, et al.. (1996). A Pilot Study of Thymosin-α1 Therapy for Chronic Hepatitis D. Journal of Clinical Gastroenterology. 23(2). 162–163. 7 indexed citations

13.

Belli, L, Enrico Maria Silini, Alberto B. Alberti, et al.. (1996). Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation. Liver Transplantation and Surgery. 2(3). 200–205. 27 indexed citations

14.

Mels, Guido Colloredo, G. Bellati, Gioacchino Leandro, et al.. (1994). Fluctuations in viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations. Liver International. 14(4). 175–181. 53 indexed citations

15.

Belli, L, Luciano De Carlis, G. F. Rondinara, et al.. (1994). Prospective randomized trial of steroid withdrawal in liver transplant patients: preliminary report. Transplant International. 7(s1). 88–90. 6 indexed citations

16.

Leadbeater, L., et al.. (1993). Antibodies Developing Against a Single Recombinant Interferon Protein May Neutralize Many Other Interferon-α Subtypes. Journal of Interferon Research. 13(2). 121–125. 25 indexed citations

17.

Bonino, Ferruccio, Guido Colloredo Mels, G. Bellati, et al.. (1993). Problems in diagnosing viral hepatitis.. Gut. 34(2 Suppl). S36–S38. 4 indexed citations

18.

Idéo, G., et al.. (1988). Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: A prospective, randomized study†. Hepatology. 8(1). 6–9. 129 indexed citations

19.

Idéo, G., et al.. (1985). Urinary D-glucaric acid excretion in the Seveso area, polluted by tetrachloro-dibenzo-p-dioxin (TCDD): five years of experience.. Environmental Health Perspectives. 60. 151–157. 22 indexed citations

20.

Annoni, G, et al.. (1978). Total serum bile acids sensitivity during therapy of chronic active liver disease.. PubMed. 41(11-12). 643–52. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact